The new variant is likely to cause severe symptoms. The findings of the pathogenicity evaluation show increased disease severity and point towards the need for screening of vaccine efficacy. The findings of the pre-print study has been published online on bioRxiv.
from Industry-Economic Times
Read The Rest:economictimes...